412.1 Long-term (2 years) survival of porcine to nonhuman primate life-sustaining kidney xenotransplantation
Ahmad Karadagi, United States
412.2 Are xenotransplantation experiments in brain-dead human subjects (decedents), justified?
Dr. David K Cooper, United States
412.3 Analysis of PERV-C superinfection resistance using HA-tagged viruses
Mrs. Merle Flecks, Germany
412.4 Routine cold storage (5 hours) leads to hyperacute graft loss in pig-to-primate kidney xenotransplantation; hypothermic machine perfusion may be preferred preservation modality
Dr. Yu Hisadome, United States
412.5 Effective detection and elimination strategies for porcine viruses
Dr. Joachim Denner, Germany
412.6 Anti-pig Antibodies in Human Immunoglobulin Preparations
Massimo Mangiola, United States
412.7 Genetic knockout of porcine GGTA1 or CMAH/GGTA1 is associated with the emergence of neo-glycans
Prof. Heiner Niemann, Germany
412.8 Anti-pig antibodies monitoring In The First Cardiac Xenotransplantation From Genetically Engineered Pig to a Human
Dr. Tianshu Zhang, United States
412.9 Immune Monitoring of The First Cardiac Xenotransplant From Genetically engineered pig to a Human